A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2011
10/19/2011	EP2376121A1 Osteoarthritis treatment
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP1937250B1 Ligustilide derivatives for the treatment of inflammatory disorders
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1282615B1 Chroman derivatives as estrogenic compounds
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN102224156A Protease inhibitors
10/19/2011	CN102224155A Protease inhibitors
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102218131A External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones
10/19/2011	CN102218130A Pharmaceutical composition for treating arthralgia syndrome and preparation method thereof
10/19/2011	CN102218124A Special traditional Chinese medicine wine for oral administration for treating rheumatism bone disease
10/19/2011	CN102218119A Chinese herbal medicine for treating rheumatism, femoral head necrosis and puerperal fever
10/19/2011	CN102218095A Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
10/19/2011	CN102218094A Chinese medicinal preparation for treating traumatic injury and preparation method thereof
10/19/2011	CN102218093A Externally applied traditional Chinese medicine for treating lumbar intervertebral disc herniation and preparation method thereof
10/19/2011	CN102218089A Chinese medicine preparation capable of increasing bone density and improving osteoporosis and arthralgia
10/19/2011	CN102218081A Manufacturing method of crocodile bone powder
10/19/2011	CN102218075A Composition for down-regulating pro-inflammatory markers
10/19/2011	CN102218072A Pharmaceutical composition for treating calcium deficiency, and preparation thereof
10/19/2011	CN102218058A Application of sparstolenin B as TLR2 (Toll-like receptor 2)/TLR4 (Toll-like receptor 4) antagonist in pharmacy
10/19/2011	CN102218053A Application of luteolin in preparation of medicaments for inhibiting angiogenesis
10/19/2011	CN102218018A Brewing container and brewing method of liquid medicine for treating hyperosteogeny and lumbar intervertebral disc herniation
10/19/2011	CN102217883A Chinese medicinal pillow capable of treating cervical spondylopathy
10/19/2011	CN102217878A Gear-shifting Chinese medicine pillow
10/19/2011	CN102217876A Thyme pillow
10/19/2011	CN102217757A Plant superoxide dismutase buccal tablets and preparation method thereof
10/19/2011	CN101987118B Food therapy health care wine for treating rheumatoid diseases and rheumatism
10/19/2011	CN101574413B Traditional Chinese medicine preparation for curing rheumatoid arthritis and preparation method thereof
10/19/2011	CN101528215B Compositions of chk1 inhibitors and cyclodextrin
10/19/2011	CN101288711B Chinese medicinal composition for treating arthritic and its preparation method
10/19/2011	CN101181601B Externally used detumescence ding-tong wine for curing orthopaedics illness
10/19/2011	CN101095671B Iguratimod oral double-layer sustained-release preparation
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	CA2579207C Morpholine compound
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2466499C Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/13/2011	WO2011126852A2 Treatment of gout
10/13/2011	WO2011126833A2 Anti-inflammatory factors
10/13/2011	WO2011126264A2 Method for increasing activity in human stem cell
10/13/2011	WO2011124992A1 Substantially pure strontium ranelate
10/13/2011	WO2011124894A1 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
10/13/2011	WO2011068927A3 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11B-HSD1) INHIBITORS AND USES THEREOF
10/13/2011	US20110252486 Chondrocyte-like cell, and method for producing same
10/13/2011	US20110251593 In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs
10/13/2011	US20110251274 Natural Vitamin E Compositions with Superior Antioxidant Potency
10/13/2011	US20110251250 Use of dimiracetam in the treatment of chronic pain
10/13/2011	US20110251224 Spiro-oxindole compounds and their uses as therapeutic agents
10/13/2011	US20110251211 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/13/2011	US20110251206 Squaramide derivatives as CXCR2 antagonist
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251158 Fullerene therapies for inflammation and inhibition of build-up of arterial plaque
10/13/2011	US20110251154 Sulfated polysaccharide compound and the preparation and use thereof
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251140 Peptide antagonist of interleukin-15 activity
10/13/2011	US20110251131 Deuterated 2-amino-3-hydroxypropanoic acid derivatives
10/13/2011	US20110251130 Methods and Compositions for Promoting Bone Growth
10/13/2011	US20110251124 Regulation of mineral and skeletal metabolism
10/13/2011	US20110251122 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
10/13/2011	US20110250297 Treatment of Hyperproliferative Disorders Using Cardiac Glycosides
10/13/2011	US20110250289 Bone substitute and method for the preparation thereof
10/13/2011	US20110250219 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250205 Anti-sclerostin antibodies
10/13/2011	US20110250203 Anti-cd5 antibodies
10/13/2011	US20110250201 Antagonists of il-6 to raise albumin and/or lower crp
10/13/2011	US20110250198 ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250190 Pharmaceutical preparation
10/13/2011	US20110250181 Human lysosomal proteins from plant cell culture
10/13/2011	US20110250180 Ccn3 peptides and analogs thereof for therapeutic use
10/13/2011	US20110250169 Derivatives of growth hormone and related proteins
10/13/2011	US20110250167 Method for purifying proteins
10/13/2011	CA2828315A1 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
10/13/2011	CA2794798A1 Treatment of gout
10/12/2011	EP2374884A2 Human miRNAs isolated from mesenchymal stem cells
10/12/2011	EP2374870A2 Use of OP-1 for the preparation of a pharmaceutical composition for reparing a defect locus in a non articular cartilage tissue of a mammal
10/12/2011	EP2374819A1 Antibodies to MASP-2
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2373789A1 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
10/12/2011	EP2373682A1 Treatment of early-stage osteoarthritis
10/12/2011	EP2373663A1 Thienopyridines as pharmacologically active agents
10/12/2011	EP2373645A1 Isoindolinone and related analogs as sirtuin modulators
10/12/2011	EP1893191B1 Medicinal acidic cannabinoids
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011	CN102216300A Compounds and compositions as protein kinase inhibitors
10/12/2011	CN102216268A Novel estrogen receptor ligands
10/12/2011	CN102215835A A medicinal product and treatment
10/12/2011	CN102215833A Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis

1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 820